Quantcast

Latest Pharmacogenomics Stories

2014-10-17 23:04:35

Assurex Health and CAMH have been awarded a $6 Million Grant from Genome Canada to study the benefits of genetic testing to guide mental health medication decisions; schizophrenia patients are included for the first time in a study of this type. Mason, OH (PRWEB) October 17, 2014 Assurex Health and Canada’s Centre for Addiction and Mental Health (CAMH) today announced they have received a $6 million grant from Genome Canada, an agency of the Canadian government, to study the benefits of...

2014-08-06 08:33:23

LONDON, Aug. 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Companion Diagnostics in Personalized Medicine and Cancer Therapyhttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/companion_diagnostics_personalized_medicine_cancer_therapy.html Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

2014-06-24 08:29:42

Pharmacogenomic test now available to help guide clinicians' medication decisions for veterans being treated for mental health conditions MASON, Ohio, June 24, 2014 /PRNewswire/ -- Assurex Health today announced that the U.S. Department of Veterans Affairs (VA) has approved its Federal Supply Schedule (FSS) contract as a government supplier, effective June 15, 2014, making the GeneSight(®) Psychotropic test available for use in VA facilities nationwide. The Veterans Health...

2014-06-09 08:28:20

Large amounts of information generated by gene expression profiling will increase implementation of data management tools LONDON, June 9, 2014 /PRNewswire/ -- Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on genetic disposition. Recent technology advances in this area are in fact enabling personalized medicine, where physicians provide patients with tailor-made treatment plans to fight diseases. Cases of cancer, cardiovascular...

2014-05-07 16:32:49

LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Personalized Medicine Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/treatments/personalized_medicine_partnering_terms_agreements.htmlComprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.The Personalized Medicine Partnering Terms and Agreements report...

2014-05-04 08:21:24

GeneSight Psychotropic Expands to Cover 38 FDA-Approved Antidepressant and Antipsychotic Medications MASON, Ohio, May 4, 2014 /PRNewswire/ -- Assurex Health today announced an enhancement of its GeneSight® Psychotropic test, providing clinicians with the most comprehensive genetic-based tool available to help them make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, post-traumatic stress disorder (PTSD), bipolar disorder,...

2014-04-30 08:32:53

GeneSight® Analgesic Test Now Includes 22 Opioids and Non-opioid Pain Medications MASON, Ohio, April 30, 2014 /PRNewswire/ -- Assurex Health, Inc. today announced a significant expansion of its GeneSight® Analgesic test. The expanded test gives clinicians a multi-gene pharmacogenomics tool to guide medication decisions for patients with acute or chronic pain using patients' own genetic profiles to help determine their potential response to 22 medications across four relevant...

2014-04-08 08:32:18

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t2pjhw/personalized) has announced the addition of a new report "Personalized Medicine - Scientific and Commercial Aspects" [http://www.researchandmarkets.com/research/t2pjhw/personalized ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The aim of personalized medicine or individualized treatment is to match the right drug to...

2014-04-03 09:57:22

Little research on the treatment of rare and orphan diseases has been conducted in this area From 1997 to 2010, despite promises made by the international scientific community, pharmacogenomic research produced few studies focusing on rare, orphan and tropical diseases prevalent in developing countries. Catherine Olivier, bioethics research at the University of Montreal's School of Public Health, recently published these findings in the journal Global Public Health. Pharmcogenomics is a...

2014-03-19 23:24:32

General Genetics Corporation (GGC) announces a new pharmacogenomic testing study that investigates the frequency of adverse drug effects on a select population with known genetic variations that affect drug metabolic pathways, to determine if pharmacogenomic testing can ameliorate risks. Las Cruces, New Mexico (PRWEB) March 19, 2014 General Genetics Corporation (GGC) announced today an investigative study of pharmacogenomic testing (PGx) value when managing criteria-specific patients who...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related